Search

everythinglearnresearchcommunity

for

Search:↓

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Doctors should watch for and treat hormonal issues in obese patients beyond just diabetes.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

The normal human prostate does not significantly affect blood DHT levels.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Best results found using acetonitrile, water, and trifluoroacetic acid or methanol mixture.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.